Neglected tropical diseases: non-profits lead the way as private sectors lags
The Covid-19 pandemic has put extra pressure on research for neglected tropical diseases, but developments continue
By
Therapy Area
Latest in
Therapy Area
HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
Pfizer and BioNTech enter $3.2bn deal with US Government for Covid-19 shots
This deal might comprise Omicron-adapted Covid-19 vaccines contingent on obtaining the US FDA authorisation.
Japan’s MHLW accepts GSK’s submission for shingles vaccine in adults
The filing is based on data from six clinical trials in subjects of the age 18 years and above.
EC grants approval for Kite’s cell therapy to treat follicular lymphoma
The latest approval is based on findings from the Phase II ZUMA-5 trial in 122 relapsed or refractory FL patients.
Astellas and Sutro partner to develop immunostimulatory ADCs
Sutro could be eligible for milestone payments of up to $422.5m for each product candidate.
EMA CHMP recommends AstraZeneca-Merck’s Lynparza for breast cancer
The latest development is based on findings from the global Phase III OlympiA trial of Lynparza.
Rensselaer team receives NIAID grant to develop antiviral drug for Covid-19
Seven of the ten hepatitis C therapies analysed were found to suppress the SARS-CoV-2 virus.